Oncocytology (Cytological Cancer Screening)
Purpose of the test:
Oncocytology is a laboratory test aimed at detecting atypical (precancerous and cancerous) cells in material obtained from mucous membranes or affected tissues.
The test helps detect oncological and precancerous changes at early stages.
Particularly recommended when tumor processes, chronic inflammation, dysplasia are suspected, and after visualization of pathological foci.
Biomaterial: Smear or scraping from affected area
- Avoid vaginal, rectal, and irritating procedures for 24-48 hours (for mucosal oncocytology).
- Material collection is performed strictly as prescribed by a physician.
Medications: if possible, avoid drugs affecting cellular status (local antibacterial, hormonal agents) 24-48 hours before the test.
What the test assesses:
- Presence of atypical cells — suspicion of malignant process.
- Cellular morphological changes — signs of dysplasia or neoplasia.
- Assessment of pathology degree — stage and severity of changes.
- Normal: cells without signs of atypia.
- Precancerous changes: cells with minor morphological deviations detected.
- Pathological changes: atypical or cancerous cells detected, requiring further examination and histological confirmation.
Which doctor to consult:
- Oncologist — when tumor processes are suspected.
- Gynecologist — for pathological cervical cytology.
- General practitioner — initial assessment and referral.
- Surgeon — for clarifying the nature of changes.
